Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oger

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Archives of Neurology|November 1, 1991
Empirical support for psychological profiles observed in multiple sclerosisE A Boyle, C M Clark, H Klonoff, et al.
Archives of Neurology|June 1, 1992
Sleep disturbance, depression, and lesion site in patients with multiple sclerosisC M Clark, J A Fleming, D Li, et al.
Science (New York, N.Y.)|January 31, 1975
Secretion of a nerve growth factor by primary chick fibroblast culturesM Young, J Oger, M H Blanchard, et al.
Annals of Neurology|July 18, 2001
Potassium channel antibodies in two patients with reversible limbic encephalitisC Buckley, J Oger, L Clover, et al.
Nature Medicine|October 4, 2000
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study GroupL Kappos, G Comi, H Panitch, et al.
Neurology|July 1, 1989
The lesion of multiple sclerosis: imaging of acute and chronic stagesR A Koopmans, D K Li, J J Oger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 yearsG V McDonnell, J Cabrera-Gomez, D B Calne, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1975
[Genic and antigenic frequencies of ABO, Rhesus(D) systems and HLA in Ille et Vilaine]B Genetet, R Fauchet, M Kerbaol, et al.
Leukemia|March 1, 1996
HTLV-I associated adult T cell leukemia/lymphoma: report of two cases from an Amerindian population in coastal northwest British ColumbiaR D Gascoyne, S M Kim, J J Oger, et al.
Mechanisms of Ageing and Development|September 1, 1983
Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humansJ P Antel, J J Oger, L G Wrabetz, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Archives of Neurology|November 1, 1991
Empirical support for psychological profiles observed in multiple sclerosisE A Boyle, C M Clark, H Klonoff, et al.
Archives of Neurology|June 1, 1992
Sleep disturbance, depression, and lesion site in patients with multiple sclerosisC M Clark, J A Fleming, D Li, et al.
Science (New York, N.Y.)|January 31, 1975
Secretion of a nerve growth factor by primary chick fibroblast culturesM Young, J Oger, M H Blanchard, et al.
Annals of Neurology|July 18, 2001
Potassium channel antibodies in two patients with reversible limbic encephalitisC Buckley, J Oger, L Clover, et al.
Nature Medicine|October 4, 2000
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study GroupL Kappos, G Comi, H Panitch, et al.
Neurology|July 1, 1989
The lesion of multiple sclerosis: imaging of acute and chronic stagesR A Koopmans, D K Li, J J Oger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 yearsG V McDonnell, J Cabrera-Gomez, D B Calne, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1975
[Genic and antigenic frequencies of ABO, Rhesus(D) systems and HLA in Ille et Vilaine]B Genetet, R Fauchet, M Kerbaol, et al.
Leukemia|March 1, 1996
HTLV-I associated adult T cell leukemia/lymphoma: report of two cases from an Amerindian population in coastal northwest British ColumbiaR D Gascoyne, S M Kim, J J Oger, et al.
Mechanisms of Ageing and Development|September 1, 1983
Mechanisms responsible for reduced in vitro immunoglobulin secretion in aged humansJ P Antel, J J Oger, L G Wrabetz, et al.
Pageof 13